New combo treatment may slow colorectal cancer spread
NCT ID NCT05862051
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This trial is for people with colorectal cancer that has spread to a few spots in the body but cannot be fully removed by surgery alone. After 3-4 months of standard chemotherapy, participants either continue chemotherapy alone or also receive local ablative therapy—such as surgery, radiation, or heat/cold ablation—to target remaining tumors. The goal is to see if adding this local treatment helps delay the cancer from growing further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Local ablative therapy (surgery, radiation, or heat/cold ablation)
What this could lead to
If successful, this approach could extend the time before colorectal cancer worsens, offering a new way to manage the disease.
What could go wrong
This is a very small early-phase trial with only 6 participants, so results may not apply broadly. The added procedures also carry risks like infection or side effects from radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barwon Health
Geelong, Victoria, 3220, Australia
-
Bendigo Hospital
Bendigo, Victoria, 3550, Australia
-
Border Medical Oncology
Albury, New South Wales, 2640, Australia
-
Eastern Health
Box Hill, Victoria, 3128, Australia
-
Northeast Health Wangaratta
Wangaratta, Victoria, 3677, Australia
-
Peter MaCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
St Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
-
The Northern Hospital
Epping, Victoria, 3076, Australia
-
Western Health
Saint Albans, Victoria, 3021, Australia